Diabetes and vascular disease

Diabetes, Obesity and Metabolism

Volumn 2, Issue SUPPL. 2, 2000, Pages 1-5

  Garber, Alan J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; GEMFIBROZIL; GLUCOSE; INSULIN; LIPID; METFORMIN; PRAVASTATIN; SIMVASTATIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE CONTROL; DYSLIPIDEMIA; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT CARE; POPULATION RESEARCH; RISK FACTOR; RISK MANAGEMENT; UNITED STATES;

EID: 0034526260     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Stroke incidence among white, black, and hispanic residents of an urban community. The Northern Manhattan Stroke Study
2. Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota
3. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
4. The feasibility of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM
5. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
6. Prognosis after stroke in diabetic patients. A controlled prospective study
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
9. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
11. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
12. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
13. Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction
14. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types
15. Antiplatelet therapy
16. Long-term effects of pravastatin on plasma concentration of C-reactive protein
17. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
18. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
19. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
20. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events CAPRIE